Hassan, recently directed a Bengaluru-based hospital and its two doctors to pay Rs 30 lakh compensation to the family of ...

A Japanese-led research team has developed AUN, a groundbreaking immune-independent bacterial cancer therapy that uses two harmonized bacteria to destroy tumors even in patients with weakened immune ...

Iterum Therapeutics plc (Nasdaq: ITRM) (the 'Company” or 'Iterum”), a company focused on delivering next generation oral and IV antibiotics to treat infections caused by multi-drug resistant pathogens ...

Rajkot: Detection of urinary tract infection (UTI), one of the most common infections, especially among women, is set to become quicker with a pathbreaking innovation by scientists in Bhavnagar.A team ...

Commercially Launched ORLYNVAH™ in the United States in August 2025----Extended Cash Runway into Q2 2026----Company to host conference call ...

Dear Doctors: I have had a UTI several times and know the symptoms. This last time, when I went to urgent care, they said they needed a urine culture before they could treat me. It was another day of ...

Commercially Launched ORLYNVAH in the United States in August 2025-- --Extended Cash Runway into Q2 2026-- --Company to host conference call today at 8:30amET-- DUBLIN, Ireland and CHICAGO, Nov. 14 ...

Acinetobacter baumannii is a multi-drug-resistant pathogen of urgent international concern. Here, the authors develop a protein subunit vaccine which prevents A. baumannii catheter-associated urinary ...

Urinary tract infection (UTI), which is technically an infection in any part of the urinary system, is incredibly common, especially among women. Research shows that 50% of women get at least one UTI ...

Fund manager updated portfolio less frequently than peers in last 1 year. (I.e. fund manager held stocks/bonds in the portfolio for longer duration than peers) ...

This fund is inactive, so it does not have any stocks/debt in its current portfolio.